Filing Details

Accession Number:
0000711377-17-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-22 13:55:44
Reporting Period:
2017-09-20
Accepted Time:
2017-09-22 13:55:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-20 22,200 $36.07 83,712 No 4 M Direct
Common Stock Acquisiton 2017-09-20 11,400 $39.61 95,112 No 4 M Direct
Common Stock Acquisiton 2017-09-20 5,276 $47.12 81,274 No 4 M Direct
Common Stock Disposition 2017-09-20 38,876 $71.28 61,512 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-09-20 22,200 $0.00 22,200 $36.07
Common Stock Common Stock (Right to Buy) Disposition 2017-09-20 11,400 $0.00 11,400 $39.61
Common Stock Common Stock (Right to Buy) Disposition 2017-09-20 5,276 $0.00 5,276 $47.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
97,950 2018-08-30 No 4 M Direct
86,550 2019-10-31 No 4 M Direct
81,274 2020-11-08 No 4 M Direct
Footnotes
  1. Options were granted August 30, 2013, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant
  2. Options were granted October 1, 2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
  3. Options were granted October 8, 2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant